Lyra Therapeutics (LYRA) Revenue & Revenue Breakdown
Lyra Therapeutics Revenue Highlights
Latest Revenue (Y)
$1.56M
Latest Revenue (Q)
$195.00K
Lyra Therapeutics Revenue by Period
Lyra Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.56M | 14.31% |
2022-12-31 | $1.36M | 378.25% |
2021-12-31 | $285.00K | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | -100.00% |
2018-12-31 | $1.24M | - |
Lyra Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $195.00K | -67.39% |
2024-06-30 | $598.00K | 12.41% |
2024-03-31 | $532.00K | 264.38% |
2023-12-31 | $146.00K | -73.16% |
2023-09-30 | $544.00K | 18.78% |
2023-06-30 | $458.00K | 11.71% |
2023-03-31 | $410.00K | 3627.27% |
2022-12-31 | $11.00K | -96.94% |
2022-09-30 | $359.00K | -11.79% |
2022-06-30 | $407.00K | -92.42% |
2022-03-31 | $5.37M | 1880.44% |
2021-12-31 | $271.00K | 1835.71% |
2021-09-30 | $14.00K | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | - |
Lyra Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CTMX | CytomX Therapeutics | $101.21M | $33.43M |
SPRO | Spero Therapeutics | $96.73M | $13.47M |
BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
AUTL | Autolus Therapeutics | $1.70M | - |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
CGEM | Cullinan Oncology | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
NXTC | NextCure | - | - |
TIL | Instil Bio | - | - |
NLTX | Neurogene | - | - |
ACHL | Achilles Therapeutics | - | - |
NUVB | Nuvation Bio | - | $727.00K |